In addition, the lack of comprehensive baseline biochemical data did not allow for the calculation of other well-established scores and biomarkers (i.e., alpha-fetoprotein (AFP)) in the HCC landscape. This evidence concerns the gene AFP and hepatocellular carcinoma.